je.st
news
Tag: announces
Schneider Electric Announces MWPowerlab Acquisition
2017-02-06 06:27:00| Chemical Processing
The acquisition boosts Schneiders virtual reality and augmented reality capabilities.
Tags: electric
acquisition
schneider
announces
Implico Announces Plans for Information Security Management System
2017-02-03 01:00:00| Hydrocarbons Technology
The need for organisations to give consideration to cyber security issues is becoming more important than ever before as digital transformation continues to advance rapidly.
Tags: information
system
management
security
DOE Announces $30 Million for Projects to Integrate Solar into Grid
2017-02-02 19:52:00| Electrical Construction & Maintenance
The Office of Energy Efficiency and Renewable Energy SunShot Initiative has announced up to $30 million in new projects read more
Tags: into
million
projects
grid
Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
2017-02-02 12:45:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Fourth-Quarter 2016 Worldwide Sales Were $10.1 Billion, a Decrease of 1 Percent, Including a 1 Percent Negative Impact from Foreign Exchange; Full-Year 2016 Worldwide Sales Were $39.8 Billion, an Increase of 1 Percent, Including a 2 Percent Negative Impact from Foreign Exchange Fourth-Quarter 2016 GAAP EPS Was $0.42; Fourth-Quarter Non-GAAP EPS Was $0.89; Full-Year 2016 GAAP EPS Was $2.04; Full-Year Non-GAAP EPS Was $3.78 2017 Financial Outlook Expects Full-Year 2017 GAAP EPS to be Between $2.47 and $2.62; Expects Non-GAAP EPS to be Between $3.72 and $3.87, Including an Approximately 2 Percent Negative Impact from Foreign Exchange Anticipates Full-Year 2017 Worldwide Sales to be Between $38.6 Billion and $40.1 Billion, Including an Approximately 2 Percent Negative Impact from Foreign Exchange Advanced KEYTRUDA Development Program U.S. Food and Drug Administration (FDA) Approved KEYTRUDA for Previously Untreated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have High PD-L1 Expression (Tumor Proportion Score of 50 Percent or More) Without EGFR or ALK Genomic Tumor Aberrations FDA Granted Priority Review for Three Supplemental Biologics License Applications for KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2016. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more
Tags: results
financial
announces
merck
Azelis announces distribution partnership with ANGUS Chemical Company for biotechnology and paints & coatings markets
2017-01-24 12:50:00| Chance & Hunt News
Tags: company
distribution
partnership
chemical
Sites : [395] [396] [397] [398] [399] [400] [401] [402] [403] [404] [405] [406] [407] [408] [409] [410] [411] [412] [413] [414] next »